Initial conformational changes of human transthyretin under partially denaturing conditions

Biophysical Journal

Volumn 89, Issue 1, 2005, Pages 433-443

  Yang, Mingfeng ^a   Lei, Ming ^a,b   Bruschweiler, Rafael ^a,c   Huo, Shuanghong ^a  

^a CLARK UNIVERSITY   (United States)

^b BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PREALBUMIN; TETRAMER;

ARTICLE; BETA SHEET; CONFORMATIONAL TRANSITION; DISSOCIATION; FIBROGENESIS; HYDROGEN BOND; MOLECULAR DYNAMICS; POLYMERIZATION; PROTEIN ASSEMBLY; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN SYNTHESIS; PROTEIN TERTIARY STRUCTURE; SELF ASSEMBLY; SIMULATION;

EID: 23244467144     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.105.059642     Document Type: Article

References (50)

1. Sacchettini, J. C., and J. W. Kelly. 2002. Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Discov. 1:267-275.
2. Hamilton, J. A., and M. D. Benson. 2001. Transthyretin: a review from a structural perspective. Cell. Mol. Life Sci. 58:1491-1521.
3. Blake, C. C., M. J. Geisow, S. J. Oatley, B. Rerat, and C. Rerat. 1978. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J. Mol. Biol. 121:339-356.
4. Hamilton, J. A., L. K. Steinrauf, B. C. Braden, J. Liepnieks, M. D. Benson, G. Holmgren, O. Sandgren, and L. Steen. 1993. The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30 → Met variant to 1.7-A resolution. J. Biol. Chem. 268:2416-2424.
5. Sebastiao, M. P., M. J. Saraiva, and A. M. Damas. 1998. The crystal structure of amyloidogenic Leu55 → Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J. Biol. Chem. 273:24715-24722.
6. Hammarstrom, P., F. Schneider, and J. W. Kelly. 2001. Transsuppression of misfolding in an amyloid disease. Science. 293:2459-2462.
7. Schneider, F., P. Hammarstrom, and J. W. Kelly. 2001. Transthyretin slowly exchanges subunits under physiological conditions: a convenient chromatographic method to study subunit exchange in oligomeric proteins. Protein Sci. 10:1606-1613.
8. Hammarstrom, P., X. Jiang, A. R. Hurshman, E. T. Powers, and J. W. Kelly. 2002. Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc. Natl. Acad. Sci. USA. 99(Suppl. 4):16427-16432.
9. Hurshman, A. R., J. T. White, E. T. Powers, and J. W. Kelly. 2004. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry. 43:7365-7381.
10. Jiang, X., C. S. Smith, H. M. Petrassi, P. Hammarstrom, J. T. White, J. C. Sacchettini, and J. W. Kelly. 2001. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry. 40:11442-11452.
11. Colon, W., and J. W. Kelly. 1992. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry. 31:8654-8660.
12. Lashuel, H. A., Z. Lai, and J. W. Kelly. 1998. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry. 37:17851-17864.
13. Hornberg, A., T. Eneqvist, A. Olofsson, E. Lundgren, and A. E. Sauer-Eriksson. 2000. A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J. Mol. Biol. 302:649-669.
14. Lei, M., M. Yang, and S. Huo. 2004. Intrinsic versus mutation dependent instability/flexibility: a comparative analysis of the structure and dynamics of wild-type transthyretin and its pathogenic variants. J. Struct. Biol. 148:153-168.
15. Wojtczak, A., P. Neumann, and V. Cody. 2001. Structure of a new polymorphic monoclinic form of human transthyretin at 3 A resolution reveals a mixed complex between unliganded and T4-bound tetramers of TTR. Acta Crystallogr. D Biol. Crystallogr. 57:957-967.
16. Homberg, A., A. Olofsson, T. Eneqvist, E. Lundgren, and A. E. Sauer-Eriksson. 2004. The beta-strand D of transthyretin trapped in two discrete conformations. Biochim. Biophys. Acta. 1700:93-104.
17. Yang, M., M. Lei, and S. Huo. 2003. Why is Leu55 → Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers. Protein Sci. 12:1222-1231.
18. Still, W. C., A. Tempczyk, R. C. Hawley, and T. Hendrickson. 1990. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 112:6127-6129.
19. Lai, Z., W. Colon, and J. W. Kelley. 1996. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry. 35:6470-6482.
20. Liu, K., H. S. Cho, H. A. Lashuel, J. W. Kelly, and D. E. Wemmer. 2000. A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struct. Biol. 7:754-757.
21. Klabunde, T., H. M. Petrassi, V. B. Oza, P. Raman, J. W. Kelly, and J. C. Sacchettini. 2000. Rational design of protein human transthyretin amyloid disease inhibitors. Nat. Struct. Biol. 7:312-321.
22. Pearlman, D., D. A. Case, J. W. Caldwell, W. S. Ross, T. E. Cheatham, S. DeBolt, D. Ferguson, G. Seibel, and P. A. Kollman. 1995. AMBER, a package of computer programs for applying molecular mechanics, normal-mode analysis, molecular-dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput. Phys. Commun. 91:1-41.
23. Simmerling, C., B. Strockbine, and A. E. Roitberg. 2002. All-atom structure prediction and folding simulations of a stable protein. J. Am. Chem. Soc. 124:11258-11259.
24. Onufriev, A., D. Bashford, and D. A. Case. 2004. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins. 55:383-394.
25. Tsui, V., and D. A. Case. 2000. Molecular dynamics simulations of nucleic acids with a generalized Born solvation model. J. Am. Chem. Soc. 122:2489-2498.
26. Tsui, V., and D. A. Case. 2000. Theory and applications of the generalized Born solvation model in macromolecular simulations. Biopolymers. 56:275-291.
27. Cornell, W., R. Abseher, M. Nilges, and D. A. Case. 2001. Continuum solvent molecular dynamics study of flexibility in interleukin-8. J. Mol. Graph. Model. 19:136-145.
28. Lazaridis, T., and M. Karplus. 1997. "New view" of protein folding reconciled with the old through multiple unfolding simulations. Science. 278:1928-1931.
29. Berendsen, H. J. C., J. P. M. Postma, W. F. van Gunsteren, A. DiNola, and J. R. Haak. 1984. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81:3684-3690.
30. Ryckaert, J. P., G. Ciccotti, and H. J. C. Berendsen. 1977. Numerical integration of the Cartesian equations of motion for a system with constraints: molecular dynamics of n-alkanes. J. Comp. Phys. 23:327-341.
31. Kabsch, W., and C. Sander. 1983. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:2577-2637.
32. Daffner, C., G. Chelvanayagam, and P. Argos. 1994. Structural characteristics and stabilizing principles of bent beta-strands in protein tertiary architectures. Protein Sci. 3:876-882.
33. Chatfield, C., and A. J. Collins. 1980. Introduction to multivariate analysis. Chapman and Hall, London, UK and New York, NY.
34. Ho, B. K., and P. M. Curmi. 2002. Twist and shear in beta-sheets and beta-ribbons. J. Mol. Biol. 317:291-308.
35. Prompers, J. J., and R. Bruschweiler. 2002. Dynamic and structural analysis of isotropically distributed molecular ensembles. Proteins. 46:177-189.
36. Armen, R. S., D. O. Alonso, and V. Daggett. 2004. Anatomy of an amyloidogenic intermediate: conversion of beta-sheet to alpha-sheet structure in transthyretin at acidic pH. Structure (Camb). 12:1847-1863.
37. Reixach, N., S. Deechongkit, X. Jiang, J. W. Kelly, and J. N. Buxbaum. 2004. Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc. Natl. Acad. Sci. USA. 101:2817-2822.
38. Chung, C. M., L. H. Connors, M. D. Benson, and M. T. Walsh. 2001. Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis. Amyloid. 8:75-83.
39. Olofsson, A., J. H. Ippel, S. S. Wijmenga, E. Lundgren, and A. Ohman. 2004. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J. Biol. Chem. 279:5699-5707.
40. Kelly, J. W., and P. T. Lansbury. 1994. A chemical approach to elucidate the mechanism of transthyretin and B protein amyloid fibril formation. Amyloid: Int. J. Exp. Clin. Invest. 1:186-205.
41. Serpell, L., G. Goldstein, I. Dacklin, E. Lundgren, and C. C. F. Blake. 1996. The "edge strand" hypothesis: prediction and test of a mutational "hot spot" on the transthyretin molecule associated with FAP amyloidogenesis. Amyloid: Int. J. Exp. Clin. Invest. 3:75-85.
42. Armen, R. S., M. L. DeMarco, D. O. Alonso, and V. Daggett. 2004. Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc. Natl. Acad. Sci. USA. 101:11622-11627.
43. Levin, M., M. Hirshberg, R. Sharon, and V. Daggett. 1995. Potential energy function and parameters for simulations of the molecular dynamics of proteins and nucleic acids in solution. Comput. Phys. Commun. 91:215-231.
44. Wang, J. M., P. Cieplak, and P. A. Kollman. 2000. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem. 21:1049-1074.
45. Eneqvist, T., K. Andersson, A. Olofsson, E. Lundgren, and A. E. Sauer-Eriksson. 2000. The beta-slip: a novel concept in transthyretin amyloidosis. Mol. Cell. 6:1207-1218.
46. Liu, K., H. S. Cho, D. W. Hoyt, T. N. Nguyen, P. Olds, J. W. Kelly, and D. E. Wemmer. 2000. Deuterium-proton exchange on the native wild-type transthyretin tetramer identifies the stable core of the individual subunits and indicates mobility at the subunit interface. J. Mol. Biol. 303:555-565.
47. Serag, A. A., C. Altenbach, M. Gingery, W. L. Hubbell, and T. O. Yeates. 2001. Identification of a subunit interface in transthyretin amyloid fibrils: evidence for self-assembly from oligomeric building blocks. Biochemistry. 40:9089-9096.
48. Ichiye, T., and M. Karplus. 1991. Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins. 11:205-217.
49. Choy, W. Y., and J. D. Forman-Kay. 2001. Calculation of ensembles of structures representing the unfolded state of an SH3 domain. J. Mol. Biol. 308:1011-1032.
50. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin. 2004. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.